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BELIEVE WALK FOUNDERS, from left, Nancy Varner, Annie Sellas and Cathy Stockton, release doves 
during the cancer survivors photo at the Redlands Bowl in Redlands in October. The 10th annual 
Believe Walk, presented by Stater Bros. Charities and Inland Women Fighting Cancer, is a 
grassroots event that drew nearly 12,000 participants last year. Funds raised during the event were 
donated to support local cancer-fighting organizations and cancer centers, including Loma Linda 
University Cancer Center. Donors and sponsors have raised more than $2.5 million in the fight 
against cancer since the annual event began in 2008.
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WHOLE PERSON CARE SUPPORTS 
PATIENTS NAVIGATING OPTIONS FOR 
WORLD-CLASS TREATMENT. 
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THERE ARE FEW DIAGNOSES THAT STRIKE 
FEAR INTO A PATIENT AND THEIR FAMILY’S 
HEARTS LIKE CANCER. Despite great strides 
in the last few decades, there is still great 
uncertainty that rides with this single word. 
Few families have totally escaped the impact 
of having a loved one touched by cancer.
It has touched our family three times. 
First when Linda, my sister-in-law, was 
diagnosed with what turned out to be 
fallopian tube cancer, a diagnosis that could 
now probably be cured. Watching her, and 
us, gradually move from hopeful watching to 
grudging reality, was a sobering transition. 
Even though she died 25 years ago, her 
passing still reminds our family that none of 
us are immune.
Probably the most emotional was 
our infant granddaughter Emily, born 
prematurely along with her twin sister 
Abigail. Emily was diagnosed with 
hepatoblastoma, a cancer of the liver 
associated with prematurity. She was just 
six months old. Watching her go through 
chemotherapy for months, followed by 
surgical removal of part of her liver and then 
more chemotherapy, took a toll on all of us. 
It is always a joy to hear from Emily now, 
finishing 10th grade and doing well. 
And then my own encounter with 
prostate cancer over a decade ago brought 
the disease back home again. Despite living, 
eating and checking in all the right ways, my 
genetics caught up with me. I am grateful to 
the skillful doctors with whom I trusted my 
life and future. I still look back on that period 
as a wake-up call to appreciate what one has, 
here and now, and use each moment to make 
a difference.
This issue of Scope is committed to this 
topic — what is true, what is not, and how 
To u c h e d  b y  c a n c e r ,  L I V I N G  F O R  A  C U R E
Richard H. Hart, MD, DrPH
PRESIDENT, 
LOMA LINDA UNIVERSITY HEALTH
From our President
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5Loma Linda University Health is pushing 
these boundaries. We have a group of young 
investigators exploring many new avenues 
of detection and treatment. Some may 
never work, while others could be major 
breakthroughs. But what is exciting is for 
Loma Linda University Health to be a haven 
for cancer research, a place where both 
basic and translational research can make a 
difference in the lives of thousands.
Our goal is to become a Comprehensive 
Cancer Center, a designation by the National 
Cancer Institute that signifies the best of the 
best. This is a multi-year journey, requiring 
both an internal commitment and the 
support of donors. We are grateful for the 
leadership of Mark Reeves, MD, PhD, in this 
endeavor, and are committed to taking each 
necessary step. Our plan is to have our new 
research building provide major laboratories 
to develop new cancer prevention and 
treatment modalities. We will also expand 
even further our clinical trials where patients 
can have the opportunity to be enrolled in the 
latest cancer treatments.
Together we can beat this opponent 
for good.
LOMA L INDA UNIVERSITY  
CANCER CENTER 
700+ HIGHLY SPECIALIZED DOCTORS,  RESEARCHERS AND CAREGIVERS
11 EXPERT TEAMS SPECIALIZING IN  EACH CANCER TYPE
150+ ONGOING CANCER CLINICAL TRIALS
3,000+ NEWLY DIAGNOSED PATIENTS  TREATED EVERY YEAR
1st HOSPITAL-BASED PROTON TREATMENT CENTER
35 YEARS AS AN ACCREDITED ACADEMIC COMPREHENSIVE CANCER CENTER
47 LOOK GOOD FEEL BETTER EVENTS IN 2017
67 WIG FITTINGS IN 2017
142 ATTENDANCE FOR CANCER-FIGHTING FOODS COOKING DEMONSTRATIONS
250 WOMEN ATTENDING SEMIMONTHLY CANCER SUPPORT GROUP IN 2017
SCOPE SUMMER 2018VOL. 53, NO. 2
b y  t h e  numb e r s
Updates
RESEARCHERS AT LOMA LINDA UNIVERSITY 
and a university in France have found that meat 
protein is associated with a sharp increased risk 
of heart disease, while protein from nuts and 
seeds is beneficial for the human heart. 
Their study — published online in April by 
the International Journal of Epidemiology — 
found that people who consumed large amounts 
of meat protein experienced a 60 percent 
increase in cardiovascular disease (CVD), while 
people who consumed large amounts of protein 
from nuts and seeds experienced a 40 percent 
reduction in CVD. 
The study, titled “Patterns of plant and 
animal protein intake are strongly associated 
with cardiovascular mortality: The Adventist 
Health Study-2 cohort,” was led by co-principal 
investigators Gary Fraser, MB ChB, PhD, from 
Loma Linda University, and François Mariotti, 
PhD, from AgroParisTech and the Institut 
National de la Recherche Agronomique, Paris, 
France, along with a team of researchers from 
both organizations.
The study included data from more than 
81,000 participants and represents one of the 
few times detailed sources of animal protein 
have been examined jointly with animal fat in a 
major investigation. 
“While dietary fats are part of the story 
in affecting risk of cardiovascular disease, 
proteins may also have important, and largely 
overlooked, independent effects on risk,” 
Fraser said. Fraser and his colleagues have 
long suspected that including nuts and seeds 
in the diet protects against heart and vascular 
disease, while red meats increase risk. 
Nutritionists have traditionally looked 
toward what Fraser terms “bad fats” in meats 
and “helpful fats” in nuts and seeds as causal 
agents. “This new evidence suggests that the 
full picture probably also involves the biological 
effects of proteins in these foods,” he said.
Fraser said the team’s research differed 
in another significant way from previous 
investigations. While prior studies have 
examined differences between animal and plant 
proteins, this study did not stop at just two 
categories, but chose to specify meat protein 
and proteins from nuts and seeds along with 
other major dietary sources. “This research is 
suggesting there is more heterogeneity than 
just the binary categorization of plant protein or 
animal protein,” Fraser said.
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S T U D Y  S AY S  M E AT  P R O T E I N  I S 
U N H E A LT H Y,  B U T  P R O T E I N  F R O M 
N U T S  A N D  S E E D S  I S  H E A R T  S M A R T
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O V E R  $ 2  M I L L I O N  R A I S E D  
F O R  L O M A  L I N D A  U N I V E R S I T Y 
C H I L D R E N ' S  H O S P I TA L  AT  
2 5 T H  A N N I V E R S A R Y  G A L A
THE 25TH ANNIVERSARY CHILDREN’S HOSPITAL FOUNDATION GALA, 
presented by Walter’s Automotive Group, was an evening to remember, 
raising an unprecedented $2.36 million at the March event. The theme, 
“Reflection,” celebrated the first 25 years of Loma Linda University 
Children’s Hospital and highlighted its bold plans for the future.
Scott Perryman, MBA, senior vice president/administrator of Children’s 
Hospital, told guests at the Riverside Convention Center the future is not 
possible without their support.
“Celebrating 25 years of giving is a major milestone, and it would not 
have been possible without your tireless effort on our behalf,” Perryman 
told the more than 1,000 attendees. “In that time, you have raised nearly 
$20 million! Every single one of those dollars has been part of giving 
world-class care to the children in your community.”
Funds raised will benefit Vision 2020 – The Campaign for a Whole 
Tomorrow, which supports construction of the new Children’s Hospital 
tower and Loma Linda University Children’s Health – Indio, which opened 
in that community in March.
Richard H. Hart, MD, DrPH, president of Loma Linda University Health, 
dedicated the evening to Leonard Bailey, MD, pioneer of infant heart 
transplantation; Lyn Behrens, MBBS, president emerita of Loma Linda 
University Health; and John Mace, MD, chair of pediatrics when Loma 
Linda University Children's Hospital (LLUCH). first opened its doors, for their 
vision of a hospital just for kids. “They set the standard for excellence that 
has guided the hospital to be what it is today,” Hart said.
Physicians were not the only individuals recognized. Four awards 
were presented to individuals and groups who have made significant 
contributions to the lives of children.
• The Big Hearts for Little Hearts Guilds received the Shirley N. 
Pettis Award.
• Tim and Carol Rochford received the Discover Lifetime 
Achievement Award.
• Helen Staples-Evans, DNP, MS, RN, was recognized with the 
Outstanding Clinician Award.
• Alicia Lopez was given the Hometown Hero Award. Lopez was the 
living donor who donated one of her kidneys to 3-year-old Matthew 
Castleberry. Castleberry, who has a twin sister, began receiving 
treatment at LLU Children’s Hospital while in utero due to kidney 
complications. On dialysis since birth, Castleberry received the life-
saving kidney he needed from Lopez.
After hearing the inspiring story, guests were encouraged to donate 
to support the Children’s Hospital in its mission to provide quality, whole 
child care to every patient. It was during this time that an anonymous 
donor gave $1 million toward the Loma Linda University Children’s Health 
– Indio clinic.
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Updates
THE COACHELLA VALLEY COMMUNITY 
is officially home to Loma Linda University 
Children’s Health – Indio, the largest pediatric 
clinic in the area. The grand opening was 
celebrated with a ribbon-cutting ceremony and 
the All About Kids Health Expo on March 11.
Richard H. Hart, MD, DrPH, president 
of Loma Linda University Health, shared his 
excitement as Loma Linda University Health 
expanded its service into the Coachella Valley 
to provide healthcare that is accessible and 
available to those who need it most.
“We are committed to this valley. We 
are committed to you,” Hart said. “We are 
committed to your children and the leaders they 
will become for this region.”
Nearly 400 individuals attended the 
ribbon-cutting ceremony, including Michael 
Wilson, mayor of Indio, and Congressman Raul 
Ruiz, MD.
"Families will now have access to critical 
pediatric services right here in the east 
valley, strengthening the health of our entire 
community," Ruiz said. “Today is an important 
milestone to realizing our shared vision for 
a future where everyone has access to the 
affordable care they need, when they need it.”
The clinic’s Jill and Barry Golden Pavilion 
was named in recognition of the generous gift 
from the Jill and Barry Golden, who were on 
hand for the opening celebration.
Following the ribbon-cutting was the 
inaugural All About Kids Health Expo, attended 
by over 1,000 community members who enjoyed 
free, healthy and fun activities.
Loma Linda University Children’s Health 
– Indio officially opened its doors to the 
community the following day, offering pediatric 
primary care services. During the remainder of 
2018, the clinic will roll out services such as 
urgent care, telemedicine, dentistry and other 
specialties. The nearly 13,000-square-foot 
building houses 20 patient exam rooms, three 
dental chairs and an X-ray room.
The clinic is also home to a bottomless 
bookshelf, courtesy of Scooter Golden, to 
encourage reading and literacy. Any child 
who receives care at Loma Linda University 
Children’s Health – Indio will be able to take a 
book home.
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L O M A  L I N D A  U N I V E R S I T Y  C H I L D R E N ' S 
H E A LT H  –  I N D I O  C E L E B R AT E S  G R A N D 
O P E N I N G  W I T H  R I B B O N - C U T T I N G 
C E R E M O N Y  A N D  K I D S  H E A LT H  E X P O
For more information about Loma Linda 
University Children’s Health – Indio, visit 
its website at lomalindakids.org/indio.
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LOMA LINDA UNIVERSITY HEALTH hosted 
the 7th International Congress on Vegetarian 
Nutrition Feb. 26-28, a three-day event exploring 
the theme of plant-based foods for the health of 
people, populations and the planet.
More than 700 attended, including 
researchers, physicians, nutritionists and 
scientists, who examined the latest findings on 
lifestyle practices and vegetarian nutrition that 
can be used effectively in the treatment and 
prevention of chronic diseases.
Scientific presentations and panel 
discussions centered around recent 
advancements in basic science, epidemiology 
and clinical trials in vegetarian nutrition from 
around the world.
Richard H. Hart, MD, DrPH, president of 
Loma Linda University Health, welcomed the 
international group of attendees on opening 
day. “Giving nutritional advice is as old as 
the Bible itself, but as new as the latest pill.” 
According to Hart, the study of optimum 
nutrition isn’t novel. “Seventh-day Adventists 
have been doing it for more than 150 years, and 
Loma Linda University Health has been studying 
the connections between food and health since 
the 1950s.”
The conference, held every five years, offers 
an opportunity for health professionals to learn 
from each other. Over the past 30 years, the 
congress has become the premier scientific 
conference on the health benefits of plant-
based diets.
“This scientific conference is not just about 
nutrition and dietetics,” said Joan Sabaté, 
MD, DrPH, director of the Center for Nutrition, 
Lifestyle and Disease Prevention at Loma Linda 
University School of Public Health and chair of 
the event. “Among other sciences, it integrates 
epidemiology, environmental sciences 
and education.”
In addition to the presentations, the 
conference offered various interactive social 
activities. These included morning runs with 
university faculty and leadership; culinary 
demonstrations led by Chef Cory Gheen, MS, 
RDN; Nasira Burholder-Cooley, DrPH, RDN; and 
Wendy Bazilian, DrPH, MA, RDN; an opening 
night reception; and a banquet hosted by Loma 
Linda University School of Public Health.
On Sunday, Feb. 25, the conference 
hosted a special community event — Plant 
Your Future — at Loma Linda University 
Health – San Bernardino. The pre-conference 
event featured a free cooking demonstration, 
health talks, a gardening demo and free blood 
pressure screenings.
I N T E R N AT I O N A L  V E G E TA R I A N 
C O N G R E S S  H I G H L I G H T S 
P L A N T- B A S E D  N U T R I T I O N
For updates regarding the next 
congress scheduled for 2023, 
visit vegetariancongress.org.
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LOMA LINDA UNIVERSITY SCHOOL OF 
PUBLIC HEALTH will offer a PhD degree in 
nutrition with an advanced research focus 
on plant-based nutrition, making it the only 
doctoral program in nutrition in Southern 
California. The new degree program, which 
will feature a research-based curriculum, 
will start in fall 2018. 
Sujatha Rajaram, PhD, associate 
professor and program director, said the 
school hosts the largest research cohort 
of healthy vegetarians in the world: the 
Adventist Health Studies. The studies date 
back to the 1960s and contain information 
on more than 96,000 subjects from the 
United States and Canada. 
“There are plenty of research 
opportunities,” Rajaram said, adding 
that multiple human intervention studies 
(clinical trials) on plant foods and health 
outcomes are underway at the school at any 
given time.
The school is recognized as an 
international leader in establishing and 
disseminating the benefits of plant-based 
nutrition — not only for the individual, 
but also for the health of populations 
and the planet. The school has hosted 
the International Congress on Vegetarian 
Nutrition for the last 30 years. 
The PhD degree will supplant the 
DrPH in nutrition the school has offered in 
the past.
The school will continue to offer DrPH 
degrees in health education, preventive 
care, and health policy and leadership, 
as well as a PhD in epidemiology. All the 
programs have been revamped to meet 
the 2016 competency requirements of the 
Council on Education for Public Health. 
“The refocused curriculum and degree 
offering are part of the school’s new 
strategic direction,” Rajaram said.
Rajaram noted that one major difference 
between the new PhD degree and the 
previous DrPH in nutrition is the number 
of units required for completion. Under the 
new PhD degree program, students will 
complete 72 units, while the DrPH required 
99. The culminating activity for the PhD 
program will be a research dissertation. 
Students will also be required to submit 
their research papers for peer-reviewed 
journal publication.
L O M A  L I N D A  U N I V E R S I T Y  S C H O O L 
O F  P U B L I C  H E A LT H  T O  O F F E R  P H D 
I N  N U T R I T I O N
Additional information about the PhD 
in nutrition is available by contacting 
Rajaram at srajaram@llu.edu. 
SCOPE
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EDUCATIONAL LEADERS FROM THE OREGON 
CONFERENCE OF SEVENTH-DAY ADVENTISTS 
visited Loma Linda University in January to 
thank executives for a group training program for 
school teachers designed to enhance the delivery 
of science, technology, engineering and math 
(STEM) instruction, an initiative that local church 
leaders say has helped stabilize enrollment 
in denominational schools and boosted 
instructional enthusiasm.
Nearly 800 K-12 teachers across North 
America have been trained over the past seven 
years through the Loma Linda University program, 
called Excellence in STEM Experiential Education 
(EXSEED). EXSEED enhances integrated science, 
technology, engineering and math education 
in Adventist K-12 schools by bringing together 
teachers for one-week training sessions during 
the summer.
Gale Crosby, MS, vice president of education 
for the Oregon Conference, has worked closely 
with Loma Linda University to challenge teachers 
in the Adventist school system to help prepare 
their students for careers in the medical, science 
and technology fields. The impact is already 
visible, even after just two years of participation, 
Crosby said.
“Following our conference’s participation in 
EXSEED, enrollment has stabilized in our schools, 
and our churches are showing signs of growth,” 
Crosby told a group of Loma Linda University 
executives, deans and faculty.
Richard H. Hart, MD, DrPH, president of 
Loma Linda University Health, said EXSEED is 
a way to integrate the education resources of 
the Adventist Church that can benefit a range 
of schools, such as the two-room school he 
attended in Northern Idaho as a child.
“There are still a lot of schools like that, and 
they are still just as much a part of the Adventist 
educational system as everyone else,” Hart 
said. “We’re wanting to empower teachers to 
teach STEM who may not have that strong of a 
background in those subjects.”
The EXSEED program received significant 
philanthropic support from Tom and Vi Zapara, 
said Rachelle Bussell, MA, CFRE, Loma Linda 
University Health senior vice president for 
advancement. Tom Zapara was in attendance 
at the January meeting. Zapara, a life-long 
learner, encouraged the Oregon leadership 
group and EXSEED planning group to continue 
innovation and stay faithful to the mission of 
Adventist education.
I N  O R E G O N ’ S  A D V E N T I S T 
S C H O O L S ,  R E S U LT S  S P R O U T  F R O M 
L O M A  L I N D A  U N I V E R S I T Y ' S  
S T E M  P R O G R A M
For more information about EXSEED, 
visit home.llu.edu/exseed or 
email exseed@llu.edu.
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When most freshmen were settling into college life, Robert Handysides, DDS, found himself adjusting to the 
culture shock of returning to the United States after spending much of his childhood in Africa. 
His first three months at Andrews University in Michigan required adjustments as he learned to navigate the 
college system and acclimate to colder temperatures. The Michigan snow took some getting used to, even for the 
Canadian native.
The son of missionaries was introduced to mission service at age 11 when he moved, along with his father, mother 
and sister, first to Malawi and then to Zimbabwe, where his father served as a mission medical director. The young 
man was surrounded by a different culture, opportunities for adventure and adults devoted to helping others. 
“There’s a purpose in life when you’re serving others that feeds your soul and gives meaning,” Handysides says.
The sixth dean to lead Loma Linda University School of Dentistry, Handysides stepped into his new role in 
January. He has spent much of his life serving in new roles and environments. “Every step of the way has been a 
learning curve,” he says. In this new role, the excitement and challenge are just what he’s looking for.
NEW SCHOOL OF DENTISTRY DEAN HAS YEARS OF 
LEADERSHIP EXPERIENCE AND A HERITAGE OF SERVICE
BY  G E N E S I S  G O N Z A L E Z
ROBERT HANDYSIDES
QUESTIONS WITH5
WHAT HAS YOUR EXPERIENCE AT LOMA 
LINDA UNIVERSITY TAUGHT YOU AS YOU 
CONTINUE TO ACCEPT NEW CHALLENGES?
My personality is one that seeks out challenging environments. 
At Loma Linda University, solutions come from a unified team, not 
one individual. When you take on a different role or wear a new 
hat, the support of the team is all around you. When I moved into 
administration, I felt the support of the dean, Dr. Dailey, as well as 
other members of the team. Now that I’ve been asked to serve as dean, 
I still feel the team’s support. 
WHY DID YOU PURSUE A ZOOLOGY DEGREE 
IN COLLEGE?
As a kid, I was really passionate about animals. I wasn’t a big 
chemistry or physics person. I’ve always been interested in healthcare, 
but zoology tended to deal with the life of animals and systems that fit 
my niche of understanding biology.
WHAT INSPIRED THE MOVE FROM STUDYING 
ANIMALS TO WORKING WITH TEETH?
When we were kids, my sister wanted to be a dentist and I wanted 
to be a physician. We changed somewhere along life’s journey. In college, 
I ended up choosing dentistry, and she chose medicine. Having a father 
12
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who was a physician and a mom who was a nurse while growing up in 
the mission field, the culture of service and healing defined our family. 
This was the stimulus driving me toward healthcare. 
WHAT IS YOUR FAVORITE PART ABOUT 
WORKING AS A DENTIST?
When a patient comes in with an extreme amount of pain and 
discomfort there is something extremely gratifying about being able to 
help them in a relatively short period of time. This is something I’ve 
always appreciated as an endodontist.
WHAT ARE SOME OF YOUR TOP AREAS OF 
FOCUS AS THE SCHOOL DEAN?
We have a significant population of extremely committed 
individuals who have been here for a long time, and a time of 
retirements and transitions are coming up. This is a challenge for the 
administrative team. Another is the changing education curriculum 
related to the National Dental Board Examinations. A third challenge 
faced by the clinical world is shifting paradigms in healthcare policy. 
There are both internal and external forces at play in this. We’ll make 
sure we keep the clinics humming and provide the students with 
sufficient experiences to play in the sandbox — so to speak — of this 
changing world.
13
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Director of the Loma Linda University Cancer Center 
Mark Reeves, MD, PhD
Cancer is a formidable opponent. 
Its diagnosis can be frightening. 
One of the most emotionally 
challenging parts of my job — or for 
any physician — is having to inform 
a patient of such a diagnosis. It was 
hard the first time I had to do it, and 
it’s still hard.
It’s difficult because even 
when patients end up doing well, 
a physician knows this diagnosis 
will be a life-changing experience 
for the patient. They’ll have to go 
to a doctor’s office many times, get 
treatments — then, even after they go 
through curative treatment, they may 
need long-term follow-up. So when 
I tell a patient that they have cancer, 
I understand what it’s going to mean. 
It’s a very sobering thing for me.
But it’s often also a very inspiring 
thing. Most patients who receive 
this diagnosis have to come face-to-
face with their mortality. However, 
when a lot of people might be afraid 
and not willing to face the problem, 
patients usually take the approach 
of: “Let’s do what needs to be done.” 
They also often take a very altruistic 
approach and ask things like, “What 
can I do to help the next person who 
has to go through this?” Many wish 
to volunteer to enroll in a clinical 
trial to help future patients do better. 
Their altruism and their practical 
approach to life-changing, sobering 
circumstances are very inspiring 
to me.
This is an exciting time for the 
Loma Linda University Cancer 
Center. We’re training the next 
generation of cancer professionals, 
translating scientific discoveries 
into state-of-the-art cancer care and 
moving toward a national designation 
that would help us play a larger role 
in fighting cancer. 
In upcoming pages, you’ll learn 
about our all-encompassing support 
network, including prevention, 
psychosocial support, treatment 
options, as well as how technology is 
involved in the battle now more than 
ever before.
Most important in the battle 
against cancer is research. There are 
more than 75 active clinical trials in 
the Cancer Center, and more than 
1,000 patients are enrolled in these 
trials each year. In addition, the 
Cancer Center’s approach to research 
and its translation into clinical care is 
being guided by a strategic pathway 
toward the National Cancer Institute 
designation as a Comprehensive 
Cancer Center, which you’ll learn 
more about at the end of this section.
You can also learn more 
by visiting the Loma Linda 
University Cancer Center website 
at lluh.org/cancer-center.
Cancer is a formidable opponent, 
and we’re committed to helping fight 
the battle with you.
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Genetic testing available at the Loma Linda University 
Cancer Center offers the best chance for prevention or early 
detection in people with high-risk factors, such as a strong 
family history of certain cancers. 
The DNA in blood or saliva can reveal information 
on dozens of genes, identifying genetic abnormalities 
that raise cancer risk significantly more than the 
general population’s. The Cancer Center utilizes 
genetic testing, when appropriately indicated, 
for certain cancer types including breast, 
ovarian, uterine, prostate, colorectal 
and pancreatic, all of which can run 
in families.
This testing is truly a case 
where knowledge equals 
power, says Sharon Lum, 
MD, medical director 
of the Breast Health 
Center at the 
Cancer Center.
“These results 
are actionable,” she 
says. “They are 
more actionable 
than most 
things we do 
in medicine.”
For several 
types of cancers, 
the Cancer Center 
can test both patients 
already diagnosed 
with the disease and 
people identified at high-
risk for harboring a cancer 
gene. For the latter, the genetic 
testing results may indicate the 
need for more frequent cancer screening than the general 
population, or for preventive measures. Genetic testing can 
also influence the treatment they receive to lessen the chance 
of cancer recurring.
In the case of breast cancer, for example, which can strike 
men as well as women, a patient with a BRCA1 or BRCA2 
gene mutation is about five times more likely to have cancer 
return a second time than a patient without the BRCA1 or 
BRCA2 mutations.  
Family members can also be positively impacted by the 
discovery of genetic mutations, revealing whether they should 
also be tested. 
Lum chose to be tested herself, because her father carries 
the BRCA1 genetic mutation, which increases risk for 
ovarian, breast, prostate and pancreatic cancers. Fortunately, 
the mutation was not passed on to her. 
The technology for genetic testing has evolved rapidly 
over the past few years, making it faster and more affordable. 
Because it uses multigene testing panels, the Cancer Center 
sometimes discovers that a patient has high risk for a 
different type of cancer entirely than they were testing for. 
“With a drop of blood, you can literally test for hundreds 
of different things,” Lum says.
Though such testing is also now available directly to 
consumers, Lum warns that these companies may not 
meet the high standards of laboratories used by hospitals, 
geneticists and physicians. Nor can such companies offer the 
necessary medical follow-up support.
The Cancer Center recommends that individuals discuss 
their possible cancer risks with a physician. A statement to 
start the conversation can be simple, such as “I'd like to talk to 
you about getting screened for cancer.”
When genetic testing is indicated, Lum says doing so 
proves true a second adage beyond “Knowledge is power.” 
Traceable to the 13th century, the 800-year-old wisdom says, 
“An ounce of prevention is worth a pound of cure.”
ANSWERS
BY HEATHER REIFSNYDER
within a drop of BLOOD
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Treatment advances that harness the 
patient’s own immune system to fight 
cancer are allowing doctors at Loma Linda 
University Cancer Center to help people 
who couldn’t be saved even just a few 
years ago.
Immunotherapy, which utilizes or 
enhances various components of the patient’s 
immune system to fight cancer, has created 
a paradigm shift in cancer research and 
treatment, says Mark Reeves, MD, PhD, 
director of Loma Linda University Cancer 
Center. Thanks to this approach, for the 
first time in the history of cancer treatment, 
therapies are being deployed and developed 
that are “site agnostic” — meaning they can 
treat any and all types of cancer.  
As a result, fewer and fewer cancers will 
be considered a death sentence.
In melanoma, this possibility is already 
becoming reality; immunotherapy has raised 
five-year survival rates for patients with a non-
operable recurrence from 10 percent or less 
to 80 percent or above, says Frank Howard 
IV, MD, PhD, who specializes at the Cancer 
Center in melanoma and unusual tumors.  
“Getting the immune system to fight 
cancer has been the holy grail of cancer 
therapy for decades,” Howard says. “It is 
certainly gratifying to be able to help people I 
couldn’t help before.”
What’s more, immunotherapy has 
few unpleasant side effects, making it 
more tolerable for weakened patients than 
chemotherapy or radiation.
“Immune checkpoint therapy” is one of 
two classes of immunotherapies the Cancer 
Center is offering, with “antibody therapy” 
being the second. The latter injects antibodies 
specific to the cancer cells into the patient’s 
blood that focus the immune system on 
the cancer. Antibody therapy currently 
shows greatest results in lymphoma and 
breast cancer.
Checkpoint therapy may actually make 
patients immune to the return of their cancer, 
similarly to how people only get chicken 
pox once.
Cancer can be so deadly because it rapidly 
mutates to outsmart treatment. One such 
mutation destroys a normal cellular pathway 
called “mismatch repair” that helps a cell heal 
itself. Freely replicating in their mutated state, 
the cancer cells produce abnormal proteins 
that signal the immune system to back off. 
But the cancer cells’ evolved inability 
to become normal again also makes them 
vulnerable to checkpoint inhibitors, which 
are injected into cancer patients and call the 
immune system back with deadly accuracy 
against the faulty cells.
“In the future, we will not primarily plan 
treatment based on location of the cancer’s 
origin in the body,” Reeves says. “We will ask 
whether a patient’s cancer has a defect in the 
mismatch repair pathway.”
Already becoming mainline therapy 
against cancers that previously lacked effective 
treatment options, immune checkpoint 
therapy shows promise not only with 
melanoma, but also Hodgkin’s lymphoma, 
lung cancer, some types of gastric and 
esophageal cancers, and bladder cancer. It is 
actually now approved for all cancers that have 
a defective mismatch repair pathway.
Upcoming in cancer immunotherapy is 
a combination of checkpoint therapy with 
vaccines, which is currently in human trials. It 
is hoped this double-edged sword will make 
cancer cells highly visible to the immune 
system while also magnifying the system’s 
cancer-killing power.
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Frank Howard IV, MD, PhD, says  
immunotherapy is helping raise  
five-year survival rates for many 
patients battling cancer.
IMMUNE TO CANCER’S RETURN?
THE DAY COULD BE COMING
BY HEATHER REIFSNYDER
The body’s immune system can be stimulated to help destroy cancer cells
17
VOL. 53, NO. 2 SUMMER 2018SCOPE
Battling Cancer
BY LARRY BECKER
Whole person care for patients battling 
cancer includes crucial psychosocial support.
Resource Center Offers 
Cancer Care tobody, mind
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A unique resource center housed within Loma Linda 
University Health offers a single location for patients to access 
services and information designed to treat more than the 
clinical and medical aspects of a cancer diagnosis. 
The Stater Bros. Charities and Inland Women Fighting 
Cancer Patient Resource Center advances Loma Linda 
University Health’s mission to provide whole person care, not 
just treat disease. Cancer patients are often overwhelmed with 
anxiety as they go through testing and diagnosis. They’re also 
flooded with information about their medical condition and 
potential treatment paths.
“Our services provide focused support to the psychological, 
social and spiritual aspects of our patients’ lives,” says Tamie 
Vasquez, CLM, CLMC, coordinator for the Patient Resource 
Center. “All of those pieces must come together for a patient 
to return to total health. Our patients are not just here for a 
diagnosis and treatment. We make sure the right services are 
made available at the right time. That’s our passion.”
Each patient visiting the Cancer Center completes a distress 
screening form. A nurse navigator reviews the answers and 
can immediately refer that patient to a wide range of support 
services that will enhance the clinical side of their care.
“We automatically reach out to someone who has a high 
distress score,” says Gabriela Gutierrez, MS, MFTI, an associate 
marriage and family therapist at the Loma Linda Universtiy 
Cancer Resource Center. “Often our initial contact leads to 
therapy or ongoing support.”
Counseling
Individual, couple, group and family counseling can help assist 
in the adjustment to a life with cancer. All counselors have training 
specific to oncology needs. “Our support groups provide a safe place 
where patients can get help, when they can’t get it at home,” says 
Tamie Vasquez, Patient Resource Center coordinator.
Nutritional Support
Monthly nutrition talks help cancer patients, family members 
and the general public learn about how healthy nutrition relates to 
cancer. “These are popular because the talks focus on eating and less 
on cancer itself,” Vasquez says. Call 909-558-2262 for the schedule 
and upcoming topics.
Cooking Demonstrations
These bimonthly 90-minute cooking classes are designed to 
be interactive experiences. Knowledgeable chefs and dietitians 
show how to prepare foods that reduce cancer risk, heart disease 
and more. These are held in the Nichol Hall kitchen at the School 
of Allied Health Professions. Schedule and topics are available 
at 1-877-LLUMC-4U.
Support Groups
An ongoing Women’s Cancer Support Group provides 
opportunities to learn about topics such as stress reduction, 
symptom management, relaxation and lifestyle changes. Caregivers 
are welcome to attend the biweekly sessions at the Loma Linda 
University Behavioral Health Institute in Redlands.  
Call 909-558-2262 for dates and times.
Exercise Classes
Exercises can help open a patient’s lymphatic system, reducing 
the swelling caused by lymphedema. Patients and family members 
enjoy the supportive environments. Open to all fitness levels, the 
classes are held every Thursday at the Loma Linda Senior Center. 
Call 909-558-2262 for more information.
Appearance Center
A free community wig bank is available to women whose 
chemotherapy or radiation treatments cause hair loss. “This can be a 
very emotional issue for women,” Vasquez says. “Hair loss is such a 
visible sign of their cancer. We provide significant support to them 
at these moments.” 
Look Good, Feel Better Program
Patients can receive personal consultations with a skin-care  
professional. Free make-overs and cosmetics are available. 
Participants also learn how to keep contamination from their 
makeup. This is in partnership with the American Cancer Society.
Patient Resource Center Services
and
body, mindspirit
19
VOL. 53, NO. 2 SUMMER 2018SCOPE
Battling Cancer
Women’s Cancer Support Groups serve most of the 
Patient Resource Center’s patients. Groups are tailored to 
specific needs and are open to patients and caregivers. 
One important avenue of therapy available at the center is 
in “onco-sex therapy.” 
“Cancer is increasingly becoming a chronic illness, not 
an acute one,” Gutierrez says. “While the immediate medical 
issues may be over, it changes a person, and it changes their 
relationships. It’s important to explore what it looks like to be 
in a relationship while having cancer.” Virtually every patient 
has one conversation about this issue, with roughly 60 percent 
receiving multiple sessions to address the issue.
Gutierrez points out there are societal stigmas about 
illnesses, and it’s up to each patient to decide if they wish to 
accept or reject the stigma. Women are accustomed to identify 
parts of their body as equating with femininity and desirability. 
“The number one question most women ask is ‘Who 
would want me now?’” Gutierrez says. “‘Who wants someone 
with cancer?’ I’ve had women call themselves Frankenstein’s 
monster, feeling their bodies are completely unrecognizable.”
Gutierrez helps couples explore how cancer has affected 
their intimate relationships and addresses body-image issues. 
Couples explore how they connected with each other before 
cancer and ways they can maintain their intimate connection 
despite cancer.
“Women will say to me, ‘I feel lighter. I feel a weight has 
been lifted. I feel there’s hope,’” Gutierrez says. “It’s a privilege 
to help people move forward.”
Loma Linda University Health’s faith-based approach 
to health and healing adds an important component to the 
Patient Resource Center’s work. Being able to incorporate a 
spiritual approach is an intricate part of care — one that is 
taboo in many secular institutions.
“In many places, therapists are afraid to initiate 
conversations about God,” Gutierrez says. “They’ll wait until a 
patient brings up religion. God’s voice is a powerful voice for a 
person on this journey. I appreciate that this institution allows 
us to explore the spiritual dimensions of care.”
20
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MYTH: Patients are treated like guinea pigs.
TRUTH: Before any new treatment is used with people in clinical 
trials, researchers work for years to understand its effects on cancer 
cells and animals in the lab. They also try to determine side effects 
the treatment. Before a treatment is used on patients, it has a long 
track record of excellent results based on careful study. The truth 
is, guinea pigs are treated like guinea pigs, and patients are treated 
like patients.
MYTH: Half the group will just get sugar pills.
TRUTH: Placebos (often found in the form of sugar pills) are rarely 
used in cancer treatment clinical trials. If they are used, they are 
typically given in addition to standard proven treatments. Most 
cancer treatment trials are designed to determine if experimental 
treatments can add benefits to existing proven treatments. Patients 
are always told if the study includes use of a placebo.
MYTH: There’s no real benefit to the patient.
TRUTH: Patients are living longer from successful cancer 
treatments that are the results of past clinical trials. By taking part 
in a trial, patients may have access to a new treatment that is not 
available to people outside the trial. Science and medicine are 
always evolving. Treatments are adjusted and constantly improved. 
Often, these more-effective treatments are included in clinical trials, 
allowing participants to be among the first to benefit. 
MYTH: Research studies are only for people with no 
other options.
TRUTH: Research studies aren’t exclusively used for people who 
have cancer, let alone those who have no other options. Prevention 
trials and screening trials are also popular. These types of trials 
can reduce the threat that patients with a high risk might present, 
as well as find the disease early when it’s more treatable. In 
addition, research studies often enroll patients to determine if new 
treatments add anything to current proven treatments. All patients 
in such a study get at least the current, proven treatments.
MYTH: Clinical trials are too dangerous.
TRUTH: There are federal rules in place to help ensure the safety 
and ethics of clinical trials. In addition, the trial is subject to ongoing 
monitoring by the institution, the institutional review board (IRB) 
and the research teams. 
MYTH: Patients will have to stop all other 
medical treatments.
TRUTH: Many clinical trials include standard therapy as part of 
the study, which may be testing an additional drug to see if the 
combination is more effective.
DEBUNKING COMMON 
MISCONCEPTIONS BY JANELLE RINGER
Understanding the truth behind clinical trials can help both current and potential patients decide if a 
clinical trial is a viable option for them. Clinical trials are an enormous weapon in the fight against cancer, 
and they hold the power to prove whether a new treatment works better than current treatments.
To find out more about the clinical trials offered at Loma Linda University Cancer Center, 
visit lluh.org/cancer-center/research.
There is often confusion on the topic of cancer clinical trials. Thousands of clinical trials are conducted annually, 
and along with them come nearly as many misconceptions. 
Some people say patients are merely guinea pigs, or that half the patients enrolled are simply given sugar 
pills. These are some of the many myths that cause some patients to pause, and sometimes back out of clinical 
research trials, says Judy Chatigny, MSN, executive director of the Loma Linda University Cancer Center.  
“Clinical trials are a great way for cancer patients to get the latest treatment, and at the same time help the 
next generation of patients that will face a diagnosis of cancer,” she says.
The Cancer Center team addresses some common myths to reveal the truth behind clinical trials:
THE TRUTH BEHIND 
CLINICAL TRIALS
21
VOL. 53, NO. 2 SUMMER 2018SCOPE
Battling Cancer
Treatment of childhood cancers can take many paths at Loma 
Linda University Children’s Hospital, the only medical center of its 
kind in California’s Inland Empire. Yet for families traveling as long 
as four hours to visit, the treatment process often starts with a very 
different — and distinctly non-medical — conversation.
One Of Anguish And Love.
“So often when anything happens to a child, parents at times 
with blinding love think it’s their fault,” says Rishikesh Chavan, MD, 
director of pediatric bone marrow transplant for the hospital. “It’s 
very hard when you are sitting with the parents to explain, ‘Your child 
has cancer, and here is the plan.’ The most important thing, I believe, 
during that initial diagnostic talk is that we absolve them of their guilt.”
Serving patients from four inland California counties and Nevada, 
from birth to age 25, Loma Linda University Children’s Hospital’s 
childhood cancer program is one of the largest in the United States. As 
part of the Children’s Oncology Group, an international consortium of 
leading childhood cancer treatment and research centers, the hospital 
is on the forefront of the latest clinical trials and other best practice 
treatment protocols for all types of childhood cancers, says Albert 
Kheradpour, MD, division chief of pediatric hematology and oncology.
Parents in the region considering treatment for their children 
should know that Loma Linda University Children’s Hospital 
aggressively treats the unique biology of childhood cancer. Physicians 
and staff in addressing the family dynamics that play an important role 
in the patient’s long-term success, Kheradpour says.
“We’re not only treating 
children, we are treating the 
family as a whole,” he says.  
Part of the 343-bed children’s hospital, the Pediatric Hematology-
Oncology/Stem Cell Transplant Unit — or Unit 4800 — is a 33-bed 
facility designed specifically for inpatient treatment of children with 
cancer. The nearby Pediatric Hematology Oncology outpatient clinic 
has numerous physician exam rooms and the capability to do infusion 
therapy for 13 patients simultaneously. It also has its own pharmacy 
and basic lab.
Many young patients begin treatment at Unit 4800 before 
transitioning to regular visits at the outpatient clinic, which sees 
around 700 patient visits each month.
Both facilities feature an open floorplan that allows patients and 
siblings to interact and socialize when possible over the course of 
treatment. Child life specialists focus on keeping young patients and 
their siblings engaged and entertained, and both locations have a social 
worker on site.
The goal is to create a comfortable space for families, where many 
treatment and lab services are available in one location, says Richard 
Chinnock, MD, chief medical officer for Loma Linda University 
Children’s Hospital.
“It’s an interesting question of how to best offer treatment for 
children,” Chinnock says. “Do you create many separate rooms, which 
is more the adult method of treatment, or a more open area so kids 
can play with each other? We’re trying to support the whole child, the 
whole family.”
The children’s hospital treats all types of childhood cancer, 
where methodologies follow the best-practice protocols from the 
Children’s Oncology Group. Among the latest available treatments are 
immunotherapy trials using antibodies to target a child’s cancer cells. 
Kheradpour describes this approach as one of today’s most promising 
routes of pioneering childhood cancer treatment.
About 30 percent of children with cancer under the age of 
15 suffer either leukemia or lymphoma — cancers of the blood 
originating in the bone marrow or lymph nodes — forming the 
most common group of childhood cancers, Chavan says. A smaller 
proportion are patients with brain tumors or other solid tumors.
Allogenic bone marrow transplant, where the child’s bone marrow 
is replaced with stem cells from a different donor, is required in more 
difficult cases of leukemia or lymphoma; whereas autologous bone 
marrow transplant allows surgeons to harvest and save the child’s own 
bone marrow to be transplanted 
after high-dose chemotherapy as a 
salvage mechanism for high-risk brain 
tumor and solid tumor patients. Loma 
Linda University Children’s Hospital 
completed 24 pediatric bone marrow 
transplants in 2017 and a total of 280 
since 2007.
Infection is the greatest risk for 
pediatric bone marrow transplant 
Treating A Child’s Difficult Diagnosis 
A growing number of cancer treatments benefits 
patients, now and in the future BY  E R I C  G N E C KO W
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patients, so patients are required to live near the hospital during 
recovery. In the spirit of whole person care, the hospital helps facilitate 
housing assistance when necessary, Chavan says.
Treating childhood cancer is different than that of adults — 
children bounce back better from chemotherapy, for example. Yet 
much energy and time from medical staff goes into reassuring families 
as well, where children and young adults with growing independence 
must grapple with the shift to a secluded lifestyle in recovery.
Chavan said Loma Linda University Children's Hospital focuses 
on guiding young patients and their families through that transition, 
and also seeks to follow their recovery into adulthood, where some 
cancer survivors may experience unique health issues such as hormonal 
imbalances and fertility problems.
“It’s not just enough to cure childhood cancer. It’s to ensure they 
survive well,” he says.
The collaborative nature of childhood cancer treatment has had a 
marked impact on its success, and today, childhood leukemia carries a 
90 percent recovery rate, Kheradpour says. Part of that success is the 
result of collaborative research facilitated by sharing of data through 
the Children’s Oncology Group.
“It’s not just to benefit your child, it’s to benefit thousands of other 
children,” he says.
Treating A Child’s Difficult Diagnosis 
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A surgical oncologist at Loma Linda University Health 
is one of only eight physicians in all of Southern California 
qualified to offer a rare, and often lifesaving, procedure that 
is changing the game for patients diagnosed with stage 
IV cancer.
Maheswari “Magi” Senthil, MD, chief of surgical 
oncology and director of the peritoneal surface malignancy 
program, says peritoneal surface malignancy, or PSM, 
designates cancer that has invaded the lining of the 
abdominal cavity and metastasized to multiple organs. 
“Very few hospitals in the United States offer realistic 
hope to patients with this diagnosis,” Senthil says, 
adding that it is often considered a death sentence since 
conventional therapies rarely achieve success once cancer 
reaches stage IV.
But thanks to the two-stage surgical procedure, that is 
not the case for Senthil’s patients. In the first stage, called 
cytoreductive surgery, the physician cuts, scrapes and ablates 
tumors and cancer cells off the affected organs. In the 
second — which is known as hyperthermic interperitoneal 
chemotherapy, or HIPEC — the surgeon inserts catheters into 
the abdominal cavity and delivers heated chemotherapy drugs 
to attack the microscopic cancer cells.
Together, the two stages can take between 10 and 24 
hours, and the surgeon is required to stand the entire time. 
“It’s the mother of all operations,” she says. 
Senthil’s medical odyssey began early in life. When she 
was 5 years old, her grandfather would often ask what she 
wanted to become when she grew up. The precocious child 
had a ready answer: she wanted to be a neurosurgeon. “I 
didn’t even know what it was,” Sentil admits, “but my mother 
was a physician and I used to go with her to the hospital 
a lot.”
Back in those days, regulations were not as strict in 
Senthil’s hometown of Madurai, India, as they are today, and 
she was allowed inside the operating room to observe her 
mother perform surgery. 
“When I was 15, I became her scrub tech,” she says. “It 
was very convenient for her to have a scrub tech who lived at 
home, especially when she got called into the hospital to do 
surgery in the middle of the night. She just had to wake me 
up and I was ready.”
Senthil received her MD degree from Madurai Kamaraj 
University in 1998 and moved to Massachusetts for a year 
of research at Boston Children’s Hospital. After that, she 
completed a seven-year surgery residency at the University 
of Medicine and Dentistry of New Jersey and a two-year 
surgical oncology fellowship at City of Hope in Duarte, 
California. She learned the cytoreductive surgical procedure 
during her nine years of surgical training. While at City of 
Hope, she met Carlos Garberoglio, MD, chief of surgical 
services at Loma Linda University Medical Center, who 
invited her to start the peritoneal surface malignancy program 
she now heads at Loma Linda University Health. 
Despite the rarity of the procedure, Senthil has performed 
it over 100 times since arriving at Loma Linda University 
Medical Center in 2010. She is proud of her work.
“We have spectacular results at Loma Linda,” she 
reports. “Instead of dying in a very short time, our patients 
are often able to recover their health and live for many 
more years.”
LOMA LINDA UNIVERSITY HEALTH PHYSICIAN IS ONE OF ONLY EIGHT IN 
SOUTHERN CALIFORNIA TO OFFER LIFESAVING PSM PROCEDURE
BY JAMES PONDER
SURGICAL
ONCOLOGIST
REALISTIC 
HOPE
offers
for stage IV 
cancer patients
Read how a chance encounter on an airplane 
led Dr. Senthil to save the life of a man last year. 
Visit news.llu.edu/joseph-harouni.
24
VOL. 53, NO. 2 SUMMER 2018SCOPE
25
VOL. 53, NO. 2 SUMMER 2018SCOPE
Battling Cancer
PH
OT
O 
BY
 T
AN
YA
 M
US
GR
AV
E
SUMMER 2018SCOPEVOL. 53, NO. 2 
26
Sometimes we like to 
imagine that the most important 
things in life come with a plan, 
but for me, it wasn’t that way. 
When I first came to Loma 
Linda University in 2006, I felt 
guilty because I didn’t have some 
grand plan, to be honest. But I 
think God had a plan. 
I was studying the normal 
process by which our bodies 
make B-lymphocytes, a type of 
white blood cell. This particular 
research had drawn me in for 
various reasons, and over the 
years I studied what can go 
wrong in the development of 
B-lymphocytes, which leads 
to B-cell acute lymphoblastic 
leukemia, also known as B-ALL. 
It’s one of the most common 
childhood malignancies. 
Though I was doing research 
at the Center for Health 
Disparities and Molecular 
Medicine at Loma Linda 
University Health, I couldn’t 
help but ask the question: how 
can I help patients in the area I 
was studying? 
I was studying the pathways 
used by cytokines, a type of 
growth factor, and the role 
they play in normal B-cell 
development. It had been a 
year since I started at Loma 
Linda University when the 
first data came back linking 
a DNA-binding protein 
that I was studying to B-cell 
leukemia. Three years later, 
the signaling pathway I was 
studying in normal cells was 
linked to three things: mutation 
of that DNA-binding protein, 
Hispanic children, and high-risk 
B-cell lymphoblastic leukemia. 
One by one the things I had 
been studying were linked to 
the disease.
Most B-ALL is curable — 
about 90 percent. The other 
10 percent is what’s most 
critical. More children die of 
B-ALL than any other cancer, 
and it disproportionately 
targets Hispanic children with 
Native American ancestry — a 
common patient base at Loma 
Linda University Children’s 
Hospital. 
It was all coming together. I 
was at a place where the patients 
had the greatest need, combined 
with my studies of the two 
mutations critical for the highest 
risk B-ALL. Where I was and 
what I was studying gave me the 
perfect position to begin looking 
at therapies. 
Surprisingly, we found that 
a molecule required to produce 
leukemia killed the leukemia 
cells when they were given high 
levels of it, while also helping 
normal immune cells to grow. 
Once I had an idea of how 
it was working, I contacted 
Michael Samardzija, PhD, 
JD, associate vice president for 
research affairs at Loma Linda 
University Health. He had 
arrived just at the right time in 
early 2016 and helped me start 
Elf Zone Inc., a company in 
the new business incubator he 
started for the university.
Within six months, we were 
awarded a small-business grant 
from the National Institutes of 
Health. The goal right now is 
to work both through Elf Zone 
and the studies in our research 
laboratories to move the biologic 
molecule forward as a drug. This 
particular molecule both kills 
the leukemia cells and also helps 
normal B-cells recover and come 
back stronger, according to our 
data. 
With any innovation, it 
takes the whole world. In this 
case, it took a team of people 
from 11 countries who helped 
work on the various studies. 
The good thing is, Loma Linda 
University Health is a smaller 
institution than some, but we 
have the infrastructure to make 
things happen.
We will continue 
experiments to move the 
molecule forward as a treatment 
and try to understand more 
about the mechanisms for how 
the molecule functions. If we 
understand how it works, we 
can modify it to work better and 
learn what other drugs work 
best in combination for the 
treatment of B-ALL.
Science has always fascinated 
me. In fact, I was interested 
in medicine at first simply 
because I had never been around 
scientists before. I grew up in 
a small town of only 1,000 
people called Rising Star, Texas. 
Prior to pursuing my PhD in 
microbiology and immunology 
from the University of 
Oklahoma Health Sciences 
Center, I taught both high 
school and community college 
for eight years.
There’s this idea that 
people will be doing exactly 
the same thing for 30 years, 
but I don’t think that’s the 
model anymore. I like to 
think I’m doing something 
different — I’m moving toward 
directly impacting people 
through science.
—As told to Genesis Gonzalez 
Founder of business incubator company Elf Zone is advancing research from lab to clinic
BY KIMBERLY PAYNE, PHD, CEO OF ELF ZONE, INC. AND 
DIRECTOR OF TRANSLATIONAL RESEARCH AT LOMA LINDA 
UNIVERSITY SCHOOL OF MEDICINE AND CANCER CENTER
FOR RESEARCHER EXAMINING LEUKEMIA’S HIGH RATE IN HISPANIC CHILDREN
RIGHT PLACE, RIGHT TIME
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Cancer researcher and team
To turn off a cell’s 
switching mechanism
A stem cell is a primitive cell that 
is able to develop into a specific cell at 
the embryonic stage — perhaps skin, 
muscle or blood. But once the change 
is made, that switching mechanism is 
supposed to shut off.
Julia Unternaehrer, PhD, 
assistant professor of basic sciences 
at Loma Linda University School of 
Medicine, is working to find out why 
a cell’s switching mechanism can turn 
back on to become cancerous. Once 
a cell is a cancer stem cell, it can build 
a tumor. 
The challenging part of 
treatment, Unternaehrer says, is that 
cancer stem cells are more resistant 
to cancer drugs than any other 
cancer cells. Often when a patient’s 
cancer goes into remission, cancer 
stem cells can remain and 
later reproduce.
Unternaehrer, a former 
physical therapist who earned 
a PhD in cell biology at Yale 
University and worked 
as a research fellow 
at Harvard Medical 
School, joined Loma 
Linda University 
Health in 2013. Her 
research career has 
LOOKING FOR THE 
‘OFF’ SWITCH
focused on understanding how cancer 
and embryonic development relate.
One strategy she and her team 
are targeting is using a protein that 
has been found to turn DNA on 
and off. Called Snail, it’s one of the 
approximately 2,600 transcription 
factors of the human genome that 
can control how genes are activated. 
This transcription factor causes a 
process called epithelial-mesenchymal 
transition, or EMT — which takes 
place in embryonic development but 
is never supposed to happen again. 
In cancer cells, Snail triggers this 
dormant process and causes them 
to become migratory and act like 
stem cells.
A tumor that stays in the organ is 
obviously unhealthy, but it can turn 
deadly once its cells travel to another 
part of the body, known as metastasis.
Unternaehrer and her lab team 
have implanted ovarian tumors into 
mice, and the plan is to inject the 
mice with nano-particles loaded 
with ribonucleic acid molecules that 
can turn off Snail. If this targeting is 
found to work in mice, then the team 
could eventually prepare for clinical 
trials in humans.
She and teammate Yevgeniya Ioffe, 
MD, received a $75,000 grant from 
the school earlier this year to study 
this process. They hope eliminating a 
patient’s cancer stem cells could stop 
tumors in their tracks.
“I would love to help patients 
have a few more good years of life,” 
Unternaehrer says.
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Huynh Cao, MD, saw firsthand the 
side effects of chemotherapy after doctors 
diagnosed his mother with breast cancer in 
1995. The treatment was difficult enough on 
her body, Cao says, yet he also credits it for 
causing her subsequent acute leukemia that, 
despite a bone marrow transplant and further 
chemotherapy, claimed her life in 2010.
The experience pointed Cao toward 
what he called his “life’s work” at Loma Linda 
University Health — developing a low-impact 
and effective treatment for acute leukemia that 
lacks the side effects of current options.
“My family went through the whole 
thing, from A to Z,” says Cao, who became an 
assistant professor at the School of Medicine 
after completing a four-year hematology and 
oncology fellowship in 2017. “I just hope we 
can find something more tolerable,” he says.
Cao and his team are investigating how 
vitamin D can prompt deadly leukemia cells 
to mature — and die off — like the body’s 
normal cells. Unlike normal cells with a finite 
lifespan, cancer cells are effectively “immortal,” 
Cao says, potentially growing unchecked to 
cause diseases like acute leukemia.
His method involves a gene that converts 
inactive vitamin D to an active form. Cao says 
he uses stem cells to carry this gene to the 
bone marrow.
The modified cell activates surrounding 
vitamin D, which prompts the nearby 
leukemia cells to mature. No longer immortal, 
the leukemia cells then resume a normal 
lifespan and die off, he says.
If taken orally, high doses of vitamin D 
would be dangerous for a patient, Cao says. 
The laboratory research shows promise that 
the modified cells activating vitamin D would 
limit their effect to the area of treatment 
before dying off on their own.
Cao draws a parallel with a similar 
leukemia treatment involving vitamin A. 
Doctors once considered one particular 
subtype of leukemia, acute myeloid leukemia 
(AML) sub-type M3, extremely dangerous 
until researchers discovered vitamin A could 
prompt those types of cancer cells to mature 
and die. Today, AML sub-type M3 is one 
of the most treatable versions of the disease, 
he says.
But Cao says treatment doesn’t work on 
all subtypes of the leukemia, a cancer with 
many variations that impact bone marrow 
and blood. His vitamin D research could 
reveal a way to treat other parts of the 
leukemia spectrum.
He says the inspiration for his current 
work followed the research of Loma Linda 
University Health’s Distinguished Professor of 
Medicine and Basic Sciences David Baylink, 
MD, who discovered promise in treating 
inflammatory bowel disease with vitamin D.
“My question was — why can’t we use the 
same thing to treat leukemia?” he recalls.
Originally from Vietnam, Cao attended 
UCLA’s Geffen School of Medicine before 
working as a resident surgeon and completing 
a subsequent internal medicine residency. 
He came to Loma Linda University Health 
in 2014.
In recognition of the potential of his 
research, Cao was one of 66 researchers 
nationally to receive $50,000 in grant funding 
as part of the Conquer Cancer Foundation’s 
Young Investigator Award in 2017.  He says 
he’s looking to obtain additional funding for 
further research.
Cao’s work is currently focused in the 
lab, using blood from leukemia patients and 
involving experiments with mice. Though 
it’s unknown when a possible treatment 
could be tested in human subjects, he says 
he’s optimistic about progressing toward his 
ultimate goal.
“I want to find a cure for acute myeloid 
leukemia,” he says.
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Researcher trying to 
find a cure for disease 
that took his mother
PROMPTING 
LEUKEMIA 
CELLS TO DIE
BY  E R I C  G N E C KO W
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ANDREW WOODWARD’S  
CANCER FIGHTING SUPER FOODS 
SHORT LIST
Tips to consider: Since there is no “perfect 
food” that has all the cancer fighting benefits, 
include a variety of at least 5-9 servings of foods 
from this list daily. Choose organic foods when 
possible. Use whole foods rather than extracts 
or supplements. These foods can be prepared as 
juiced, eaten raw or lightly cooked. The amounts 
to use can be suggested by a LLU Cancer Center 
registered dietitian. Be aware that certain foods 
may need to be avoided or limited, if allergy, 
intolerances or drug interactions exist.
LYCOPENE AND  
CAROTENOID FOODS:
Acorn squash
Apricots
Beets
Bell peppers — yellow, orange or red 
Carrots
Mangos
Nectarines
Papaya
Plums
Pumpkin (and other yellow squash)
Tomatoes (cooked is preferred)
CRUCIFEROUS VEGETABLES:
Bok choy
Broccoli
Broccoli sprouts
Brussels sprouts
Cabbage and purple cabbage
Cauliflower
Kale
Turnips
GARLIC/DIALLYL  
SULFIDE VEGETABLES:
Garlic
Leeks
Onions and Spanish purple onions
Shallots
THE 
NUTRITIONIST
IS IN
30
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Patients battling cancer can struggle 
to maintain weight when undergoing 
infusion therapy or because of other 
life stresses. Many attempt to educate 
themselves about nutrition on the 
internet, where they find information 
that is often contradictory, outdated 
or marketing.
Enter Andrew Woodward, MS, RD, 
CSO, Loma Linda University Health’s 
nutritionist for the Cancer Center, 
who helps patients with a nutrition-
intervention strategy.
“I love enhancing a patient’s quality of 
life and helping them get more enjoyment 
with eating,” he says.
Woodward meets with more than 600 
new patients each year, as well as many 
more returning patients. He also offers 
monthly cooking classes on health foods 
that can battle or help prevent cancer. “We 
go into the biochemistry of why certain 
substances in foods fight cancer,” he says.
He enjoys traveling, and he brings 
his international experience with 
cultures, cuisine and seasonings into his 
presentations and individual counseling 
sessions based on a patient’s culture, diet 
preference or locale. 
Woodward’s biggest job is often 
dealing with misinformation. “The 
internet can do a lot of damage,” he says. 
Patients might start avoiding all carbs 
and all sugars, then have a poor appetite, 
lose weight and develop malnutrition. “I 
acknowledge their fears and concerns and 
put together a plan specifically for them,” 
he says.
His top tip is to eat a plant-based 
diet. He also helps infusion patients 
strategically use healthy snacks to 
maintain weight.
Woodward, a board certified oncology 
nutritionist, first had his interest piqued 
by Loma Linda University Health as 
a high school student. He remembers 
coming to the campus on a field trip 
in 1972 and eating vegetarian food in 
the cafeteria.
He went on to work in clinical 
pathology at City of Hope, located in 
Duarte, about an hour’s drive west of 
Loma Linda, and later earned a master’s 
degree in nutrition at California State 
University, Los Angeles. He then worked 
at Kaiser Permanente before joining Loma 
Linda University Cancer Center in 2009.
Woodward says he was intrigued by 
the organization’s vegetarian approach and 
its pioneering studies on nutrition. Now 
he’s a key part of helping patients nourish 
themselves through their treatment.
“I see the value of early intervention,” 
he says. “It’s encouraging to see patients 
who have a serious diagnosis receive a plan 
for nutrition direction.”
BY  A N S E L  O L I V E R 
ANDREW  
WOODWARD  
HELPS PATIENTS  
BATTLING CANCER  
FIND OPTIMUM, 
CUSTOMIZED  
NUTRITION
BEANS/LEGUMES/SOY:
Black beans
Garbanzo beans (chickpeas)
Kidney beans
Lentils
Pinto beans
Soy* beans, tofu, soy milk, 
soy nuts
Other beans and legumes
*Soy is safe for women 
with breast cancer, 
but high intake of soy 
foods may interfere with 
thyroid medications. 
WHOLE GRAINS:
Barley
Brown rice
Bulgur
Corn
Oats and oatmeal  
(steel cuts preferred)
Quinoa
Sweet potatoes/yams and 
purple potatoes
BERRIES:
Blackberries
Blueberries
Boysenberries
Cherries
Cranberries
Pomegranate
Raspberries
Strawberries
SEASONINGS: 
Basil
Dill
Garlic
Ginger
Oregano
Parsley
Rosemary
Thyme
Tumeric
These are commonly
used, but others are 
beneficial, too.
HEALTHY OILS:
Almond oil
Canola oil (rapeseed oil)
Extra virgin olive oil
Flax oil
Grape seed oil
Walnut oil
OTHER:
Apples
Asparagus
Citrus fruits
Melons
Mushrooms
Spinach
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One of the world’s most 
sophisticated research tools is 
helping cancer researchers at 
Loma Linda University Health 
discover new cancer treatments 
and resources.
John W. Morgan, DrPH, 
professor of epidemiology at 
Loma Linda University School 
of Public Health, and principal 
investigator for Regions 4, 
5, 7 and 10 of the California 
Cancer Registry (CCR), says 
the $100-million database 
provides detailed information 
about the more than 4.5 million 
cancer cases diagnosed among 
California residents since 1988. 
Without the CCR database, 
cancer researchers at Loma 
Linda University Health might 
have access to only a few dozen 
cases of certain rare cancers. But 
with the database — which is 
conveniently housed within the 
Loma Linda University Cancer 
Center — researchers can plug 
into more than 10,000 cases.
“Without that rich database, 
a lot of questions would be 
unanswerable,” Morgan says. 
“We do population-based 
research. We have access to a 
huge resource.”   
The database allows Morgan 
and his team of physicians, 
specialty fellows, faculty 
members and doctoral students 
from Loma Linda University 
School of Public Health to 
evaluate predictors of improved 
survival in cancer patients after 
diagnosis. He says the goal is 
to comb through the data to 
identify best-treatment practices. 
“The big emphasis here is that 
our research is multi-disciplinary 
and translational,” he says. 
Those terms reveal a lot 
about the goals of the team. 
Multi-disciplinary means the 
team includes various health 
specialties — such as surgical 
oncologists, medical oncologists, 
epidemiologists, biostatisticians, 
cancer registrars and data 
analysts — to attack cancer 
problems from several angles 
and viewpoints. Translational 
indicates that once researchers 
find answers to particular 
questions, they publish their 
findings in respected cancer 
journals so clinicians and other 
health researchers can apply 
best-practice prevention and 
treatment practices.
Sometimes the findings 
are surprising, especially when 
they contradict widely held 
assumptions. Morgan cites 
beliefs about race and ethnicity 
from the California Cancer Registry database
FIND ANSWERS
NEW TREATMENTS
How a team of cancer researchers
and
John W. Morgan directs Regions 4, 5, 7 and 10 
of the California Cancer Registry
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as examples. He points out that 
for many years, clinicians and 
researchers believed Black and 
Hispanic males were more likely 
to develop colorectal cancer 
than White males. 
But when Morgan and his 
team — which includes breast 
oncologist Sharon Lum, MD, 
surgical oncologist Maheswari 
Senthil, MD, chief surgeon 
Carlos Garberoglio, MD, and 
Cancer Center Director Mark 
Reeves, MD, PhD — analyzed 
the data, their findings refuted 
this assumption.
“We found that as a group, 
Black and Hispanic males 
who are well-educated and 
live in wealthy neighborhoods 
are no more likely to get, or 
die from, colorectal cancer 
than a group of White men 
having the same socioeconomic 
status,” Morgan says. “We have 
changed the thinking about race 
and ethnicity as predictors of 
colorectal cancer. Risk is more 
socioeconomically based than 
racially based.” 
The team also researches 
breast, lung and stomach cancer. 
By evaluating differences in the 
behavior of cancers originating 
from the right and left sides 
of the colon, Morgan and his 
team can predict how it will 
respond to biologic therapy 
once it spreads to the liver. This 
provides opportunity to deliver 
best-treatment practices to 
specific patients. 
“This previously 
undiscovered finding 
underscores the need for 
improved screening and 
treatment for the second 
leading cause of cancer death 
among Americans and holds 
potential for increasing survival 
for hundreds and thousands 
of colorectal cancer patients 
around the world,” Morgan says. 
In addition to this 
research, Morgan is the 
principal investigator for a 
long-term contract with the 
National Cancer Institute. 
The $4-million study, funded 
since 1995, involves cancer 
assessments in hundreds 
of California communities. 
Morgan’s finding that cancer 
occurrence in Hinkley, 
California — the city made 
famous by the movie Erin 
Brockovich — was similar to 
the average risk in the wider 
population. It resulted in 
Hinkley’s removal from the 
Centers for Disease Control 
and Prevention’s list of cancer 
clusters in the United States. 
California’s diverse 
population makes it an excellent 
resource for cancer research. 
“We can identify unique risks 
predicted by that diversity,” 
Morgan says. Although 
California is not a high-risk 
state for cancer, things are even 
better in Loma Linda and 
Redlands where socioeconomic 
factors yield fewer tobacco-
related and preventable cancers.
Morgan says clinicians bring 
the questions to the research 
team, he brings the database 
and epidemiology methods, 
and graduate students bring 
the sophisticated statistical 
analysis skills.
“Without the medical 
specialists asking the relevant 
questions, the team wouldn’t 
be translational,” he says, 
adding that the Loma Linda 
University School of Public 
Health doctoral students 
are the best data analysts 
available. Together, the team 
has published approximately 
40 papers in scientific journals 
in the last eight years, some of 
which have changed the practice 
of medicine, Morgan says. He 
predicts the team will publish 
many more, with three already 
published or accepted for 
publication during 2018.
That, of course, is good 
news for patients who will 
benefit from new insights 
and treatments these studies 
will uncover.
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A Loma Linda University School of Public 
Health researcher is trying to find out why some 
U.S. military veterans are reluctant to use a 
popular test for colorectal cancer.
The fecal immunochemical test, or FIT, 
is faster and more convenient than the other 
colorectal screening test, the colonoscopy, yet is 
often shunned by veterans.
Unlike a colonoscopy, which must be 
administered by a physician while the patient 
is sedated, FIT involves no pain and does not 
require anything to be inserted into 
the patient’s anal opening while the 
patient is sedated. It is also far less 
expensive and can be self-
administered at home.
Public health 
experts foresee a day 
when burgeoning 
demand will  
overtake the 
supply of 
gastroenterologists, 
making FIT the only 
sensible alternative. 
Seth Wiafe, PhD, MPH, director of health 
geoinformatics at Loma Linda University School 
of Public Health, is analyzing data from more 
than 17,000 patients of the VA Loma Linda 
Healthcare System to find out why U.S. military 
veterans from some zip codes, but not others, are 
less likely to comply with their doctor’s orders to 
take the FIT. 
Preliminary findings reveal zip code pockets 
within Inyo, Riverside and San Bernardino 
counties where approximately half of veterans 
do not complete the test. Wiafe uses Tapestry 
Segmentation, a geographic information system 
(GIS) developed by geomapping software firm 
Esri, to search for commonalities among zip 
codes where veterans do not support the test. 
He says people should take colorectal cancer 
seriously and cites an American Cancer Society 
prediction that some 50,000 Americans will 
die from the disease this year. Wiafe notes that 
while colon cancer is the third most common 
cancer, it has the second-highest mortality rate of 
all cancers in this country. “Timely screening in 
adults can significantly reduce the incidence and 
mortality of colorectal cancer,” he says.
Wiafe is a pioneer in the use of GIS 
technology. A native of the West African country 
of Ghana, he hopes the data will yield a formula 
for predicting whether veterans of any given zip 
code are likely to take the test or not. 
“If so, the Veterans Administration will need 
to find out how they can increase adherence in 
those areas,” Wiafe says. 
BY  JA M E S  P O N D E R
TO MAP ADHERENCE TO 
CANCER SCREENINGS
Public health researcher wants to know why some 
veterans don’t use non-invasive home test
Seth Wiafe, PhD, MPH, is director of 
health geoinformatics at Loma Linda 
University School of Public Health. 
INYO
SAN BERNARDINO
RIVERSIDE
GIS TECHNOLOGY
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The James M. Slater, MD Proton Treatment & Research 
Center has treated more than 20,000 patients from 59 
countries since it opened at Loma Linda University Health 
in 1990. It was the world’s first hospital-based proton-beam 
accelerator dedicated to the treatment of patients with 
cancer. Here are some of the center’s major milestones.
Loma Linda University Cancer Center  
James M. Slater, MD  
Proton Treatment & Research Center
M
ilestones
James M. Slater, MD, joins the Department of Radiology at Loma Linda 
University; and it begins developing a dedicated section of radiation oncology.
The first patient is treated at the Proton Treatment Center as  
Loma Linda University Medical Center becomes the world’s 
first hospital-based, treatment-dedicated proton center. 
reports that proton radiation therapy is one of the standard treatment options for prostate 
cancer. This marks the first time that protons have received such mention in the popular press.
The James M. Slater, MD Proton Treatment & Research Center celebrates its 
25th anniversary. Today, it has treated more than 20,000 patients, more than 
any other proton treatment facility in the world.
Loma Linda University Medical Center and Fermilab 
publish the engineering design report for the proton 
synchrotron and beam transport system. 
The second and third gantries begin clinical operation, and 
construction of the cancer research laboratories begins.
Based on a presentation by Dr. Slater, research begins in the NASA-sponsored 
Loma Linda University radiation medicine radiobiology laboratories.
The Proton Treatment Center is renamed 
after its founder, Dr. James M. Slater.
Dr. David Bush and colleagues report excellent results from a five-year study on 
cosmetic outcomes of partial breast radiation therapy with the proton beam.
A robotic precision patient alignment system, which further improves 
the accuracy of repeatable patient positioning, becomes operational.
1970
1990
2010
2015
1980
2000
1970
1987
1990
1997
1994
2000
2007
2010
2014
2015
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The Loma Linda University Cancer Center treats 45,000 patients each 
year, many of whom have been told by other providers there was little 
that could be done. Its approach of using teams of specialists employing a 
combination of surgery, radiation and medication is able to offer hope and 
healing to those most in need.
Now, the LLU Cancer Center is preparing for the next level in its ability 
to serve patients and help offer groundbreaking research to professionals 
worldwide. Loma Linda University Health is currently taking steps to earn a 
designation from the National Cancer Institute to become a Comprehensive 
Cancer Center, a move that would place the organization in an elite 
fraternity of institutions around the country working to defeat cancer.
The designation would create a powerhouse discovery engine for 
research, as well as give the Cancer Center an even larger translational 
capacity to send that research to the clinic. The designation would make it 
one of only 50 cancer centers in the United States to hold “comprehensive” 
status by the National Cancer Institute.
Comprehensive Cancer Centers are uniquely situated to develop 
specific treatments and medications for specific cancers, often cancers that 
are prominent in a center’s home region. They also operate in a catchment-
area system, similar to regional trauma centers. When the Loma Linda 
University Cancer Center earns “comprehensive” status, its catchment area 
will be massive, and it will work to target the region’s unique disparities. 
Other Comprehensive Cancer Centers in California are nearer to the coast. 
To the east of Loma Linda, the closest one is a 430-mile drive to Tucson, 
Arizona. To the Northeast, the closest is a 650-mile drive to Salt Lake 
City, Utah.
We’re looking to lead in helping solve problems that are unique to 
our region.
It will be several years before Loma Linda University Health officials 
present their formal submission. But steps are being put in place now, and 
the Cancer Center is aggressively recruiting for this new direction. In the 
meantime, here are ways in which supporters can help:
• Financially support the Cancer Center’s research.
• If you have cancer or know someone who does, enrollment in a 
clinical trial moves medical professionals closer to a cure. 
• Encourage friends to do screening for cancer, either through self-
examination or through an appointment with a doctor.
• Volunteer at the Loma Linda University Cancer Center. 
• Participate in community cancer awareness events, such as the 
Believe Walk in Redlands, held the first Sunday each October, or the 
Celebration of Life, the first Sunday each June.
Thank you for your support as the Loma Linda University Cancer 
Center moves toward the nation’s most prestigious honor for an oncology 
institution, and more importantly, will contribute in an even greater way to 
the battle against cancer.
Journey to 
BY JUDY CHATIGNY, EXECUTIVE 
DIRECTOR OF THE LOMA LINDA 
UNIVERSITY CANCER CENTER
Designation from National Cancer 
Institute would place Loma Linda 
University Health in elite group
Comprehensive 
Cancer Center 
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Vision 2020 is a $360-million comprehensive 
philanthropic initiative, the largest in the history of Loma 
Linda University Health. The effort also represents the 
largest investment in healthcare and education in the 
Inland Empire.
A key part of Vision 2020 is to ensure Loma Linda 
University remains a special place where students aspire 
to study and learn about our unique brand of healthcare. 
One priority is affordability, helping put this valuable 
education within reach for the most promising and 
mission-minded future healthcare workers.
Representatives from Loma Linda University School 
of Nursing recently received a call from a person acting 
as trustee for an estate. The trustee shared a story of 
how the estate holder was so impressed with the warm, 
professional care that Loma Linda University Medical 
Center nurses had provided more than 40 years ago 
that she wanted to contribute support for future nurses. 
The trustee indicated that there would be a gift of $1 
million coming to the School of Nursing. When school 
representatives went to meet with the trustee to learn 
more of the story, they received news of a second estate 
gift of $500,000, making a total bequest of $1.5 million. 
Each year, 16-24 nursing students will benefit from this 
endowment. This generous act has resulted in a nearly 
12 percent increase in scholarship funds available for 
School of Nursing students.
Since Vision 2020 was launched, people with 
abundant hearts for students have established more 
than 20 new scholarship endowment funds. In addition, 
donors have contributed to more than 100 scholarship 
funds that started before Vision 2020 began. These gifts 
provide vital financial support for students in need.
“Education is the best thing you can give a person,” 
Loma Linda University alumnus Don Hall said. And over 
the years many people have benefited from Hall’s belief 
in education. After earning a Doctor of Public Health in 
Preventive Care, Hall’s career led him 40 years ago to 
launch Wellsource, a company offering computerized 
health analysis programs. Corporations use these 
programs to help their employees better understand and 
improve their health.
Hall is continually exploring ways to have the most 
impact on helping people live healthy lives. Seeing the 
potential to shine a light on the Adventist Health Study, 
Hall and his wife, Trish, decided to fund an endowed 
chair for the School of Public Health — the Don and 
Trish Hall Research Professorship. These funds will be 
significant in supporting the important Adventist Health 
Study, the long-term series of research projects exploring 
the benefits of lifestyle and diet on disease among 
Seventh-day Adventists.
The Hall professorship is one of eight new endowed 
chairs/professorships established since the beginning 
of Vision 2020. In addition, more than 20 existing 
chairs/professorships have been expanded during 
Vision 2020. These professorships and chairs generate 
earnings from endowments, and it’s those earnings that 
support a professor’s compensation, scholarship and 
responsibilities in teaching, research and service.
Loma Linda University is dedicated to continuing 
our growing research emphasis. Throughout its history, 
university-based researchers have asked questions that 
were daring, difficult and ahead of their time: Could we 
save a newborn’s life with a transplanted heart? Could 
a beam of protons destroy cancer without damaging 
surrounding tissue? Is there a way to keep dental 
patients conscious yet comfortable during procedures? 
The world is waiting for answers to new questions 
that Loma Linda University Health is uniquely positioned 
to answer. 
Earlier this year, the Vision 2020 effort passed a 
significant milestone when it was announced that less 
than $100 million of the $360 million goal was left to 
be raised.
“We are so grateful to all who have supported the 
campaign,” said Rachelle Bussell, MA, CFRE, senior vice 
president for advancement. “Our community friends and 
university alumni who believe in our mission to continue 
the teaching and healing ministry of Jesus Christ have 
played key roles in helping us reach this point. But we 
know that we still have much work to do.”
For more information, visit lluhvision2020.org.
A  V I S I O N  C O M I N G  I N T O  F O C U S
V I S I O N  2 0 2 0  –  T H E  C A M PA I G N  F O R  A  W H O L E 
T O M O R R O W  I S  T R A N S F O R M I N G  L I V E S 
T H R O U G H  I N N O VAT I V E  E D U C AT I O N
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M O V I N G  O N  U P
The construction of a new Medical 
Center and new Children’s Hospital tower 
are the most visible aspects of the Vision 
2020 campaign.
The foundational pedestals were put in 
place last summer — all 126 of them. Each 
one was designed and built to support a 
new 16-story Medical Center and nine-story 
addition to Children’s Hospital at Loma Linda 
University Health. Now, Loma Linda’s skyline 
is undergoing a dramatic, permanent change 
with the construction of the steel frames.
There’s an urgency to completing these 
new facilities. The State of California has 
mandated stringent seismic safety regulations 
for acute-care hospital buildings, which 
must meet these new standards by the year 
2020. Facilities that have not met the new 
requirements face closure. Confronting what 
seemed to be a monumental challenge, Loma 
Linda University Health stepped forward 
in faith, placing the new hospitals as a 
cornerstone of Vision 2020. 
After considering various options to move 
forward, Loma Linda University Health leaders 
concluded that retrofitting the institution’s 
iconic cloverleaf tower, in use since 1967, 
would not be the best approach. Instead, 
constructing a new Medical Center and 
expansion of the Children’s Hospital was more 
financially responsible. New construction 
also meant an opportunity to rethink how 
healthcare is delivered in a hospital setting 
in the 21st century and create a model for 
the future.
The 126 pedestals play a key role in 
meeting the new state seismic requirements. 
The entire array will operate as “friction 
pendulum isolators,” designed to slide up to 84 
inches horizontally under the hospital structure 
during an earthquake without the building 
itself moving. Special springs to absorb 
vertical movement may also be added, which 
would make this the first hospital building 
in the world to implement such earthquake-
mitigation measures and set a new standard in 
seismic safety.
The pedestal system serving as the base 
of the new hospital is the first of its kind, said 
Kerry Heinrich, JD, chief executive officer of 
Loma Linda University Medical Center. “These 
pedestals represent the leading technology in 
the world, and they will make a real difference 
in the seismic safety of the new hospital.”
Each pedestal is 10-1/2 feet wide, 10-1/2 
feet long, and 3-1/2 feet tall, with each one 
weighing 10 tons. The units were built in 
Eloy, Arizona, and trucked to Loma Linda for 
placement. Each pedestal took about three 
weeks to assemble. 
While seismic safety is the primary 
consideration in the pedestal design, these 126 
units will be the platform for a hospital facility 
that incorporates the latest advances in patient 
care and comfort. The new building also 
supports expansion of key adult services, such 
as the Level 1 trauma center, the Emergency 
Department, the International Heart Institute 
and nearly doubles the size of the Neonatal 
Intensive Care Unit.
“There is no question this new building 
will be the foundation of another significant 
expansion of the Loma Linda University 
Health story,” said Richard H. Hart, MD, DrPH, 
president of Loma Linda University Health. “But 
the building itself only supports the people 
and events that happen inside. Students will 
learn new skills, residents will perfect their 
specialties, faculty will push the boundaries 
of science and thousands of patients will be 
blessed with a special kind of care.”
Loma Linda University Health’s mission 
statement commits the organization and its 
people to continue the teaching and healing 
V I S I O N  2 0 2 0  I S  A  $ 3 6 0 - M I L L I O N 
P H I L A N T H R O P I C  C A M PA I G N  S U P P O R T I N G 
L O M A  L I N D A  U N I V E R S I T Y  H E A LT H ’ S 
C O M P R E H E N S I V E  V I S I O N  F O R  T H E 
F U T U R E  T H R O U G H  F O U R  P R I O R I T Y  A R E A S : 
E D U C AT I O N ,  C L I N I C A L  C A R E ,  R E S E A R C H  
A N D  W H O L E N E S S .
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ministry of Jesus Christ. The new hospital facilities 
are central to fulfilling many healing objectives. 
But it’s the mission statement’s teaching emphasis 
that is a large part of why the hospital exists at 
all. The organization’s hospitals are the primary 
teaching laboratory for the thousands of students 
studying here in medicine, nursing, allied health 
professions, pharmacy, behavioral health specialties 
and chaplaincy.
Learn more at lluhvision2020.org.
Kerry Heinrich, JD, right, CEO of Loma Linda 
University Medical Center, and Eric Schilt, 
assistant vice president for construction, 
during a recent tour of the  construction site
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1. The Loma Linda University Church Orchestra and Choir 
perform during Sabbath worship, which was held in the  
Drayson Center.
2. Participants of the Sabbath morning Parade of Flags wore native 
dress from their home countries or countries where they served  
as missionaries.
3. Attendees were treated to a haystack lunch following the Sabbath 
church service. 
4, 5, 6.  Numerous alumni performed in a talent show on  
Saturday night.
7. A 5K fun run was held Sunday morning, with proceeds 
supporting scholarships for the schools of Nursing and Pharmacy. 
8. School of Allied Health Professions Dean Craig Jackson, JD, 
MSW, right, formally participated in the Sunday pickleball 
tournament along with School of Public Health Dean Helon 
Hopp Marshak.
9. Homecoming was a great chance to catch up with friends.
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When Jason Brayley, MD, applied 
to become chief of sports medicine for 
Kaiser Permanente in Sacramento, he 
was drawn to the healthcare system’s 
vision for growing its sports medicine 
practice and its approach to keeping 
people healthy.
He didn’t give much thought, if 
any, to talk of Kaiser Permanente 
potentially becoming the primary 
medical provider for the California 
capital city’s Sacramento Kings.
But about a month after the 
Yucaipa, Calif., native started his new 
job, his boss asked what he would 
think about being a Kings’ team doctor.
Brayley is now one of two 
physicians who regularly attend home 
games, responsible for the care of 
the Kings and of the visiting team, 
referees and other staff. If a medical 
issue arises before, during or after a 
game, Brayley is available to attend to 
the matter as needed.
He also acts as the Kings’ primary 
care doctor, advising and treating 
players and their families when they 
have medical needs — whether 
it’s dealing with the flu, stomach 
ailments, infections or other issues.
“It’s a 24/7 job,” Brayley says. 
“NBA athletes are human beings just 
like us with families and life stresses. 
Part of my job has been to establish 
relationships that help provide care 
in any way that the athlete or family 
may need.”
Brayley also enjoys providing the 
same level of care to the range of 
patients who walk through the doors 
of Kaiser’s sports medicine center 
inside Golden 1 Center, the Kings’ 
home arena.
Brayley’s role is one he never 
imagined for himself, though he 
can pinpoint experiences that, in 
retrospect, clearly helped set the 
stage. One is his time in medical 
school: he especially credits two 
professors — Resa Chase, MD, and 
Ben Nava, PhD — for encouraging 
him to persevere despite a trying 
first quarter.
He also points to the sacrifices of 
his family to support his education. 
His father was a psychiatric tech who 
worked two full-time jobs, and his 
mom taught second-grade. Brayley 
didn’t come from a line of doctors, but 
growing up near Loma Linda, he was 
surrounded by them. An early interest 
in physical therapy while in high 
school at Loma Linda Academy evolved 
into a desire to pursue medicine.
“It was a career that was 
interesting, that I thought was a good 
calling, so I went for it,” he says.
He attended Pacific Union College 
in Northern California’s Napa Valley 
before going on to Loma Linda 
University School of Medicine in 
1997. He grew interested in family 
medicine as he completed rotations 
at military hospitals, which were 
required for the U.S. Navy scholarship 
that paid for his last three years of 
medical school. After graduating 
in 2001, he completed a three-year 
family medicine residency through the 
Naval Hospital Camp Pendleton on the 
Marine Corps base north of San Diego, 
followed by three years of service at 
Naval Air Weapons Station China Lake 
in the western Mojave Desert.
A sports medicine fellowship 
at Ohio’s Cleveland Clinic — the 
healthcare provider for the Cleveland 
Cavaliers — began laying the 
groundwork for his future practice. 
Working under team doctors for a 
year gave him an up-close view of the 
rhythms and requirements of being 
an NBA physician. At the same time, 
he volunteered as doctor for a cycling 
team, a role he performed until 2013, 
further expanding his experience in 
caring for professional athletes.
S C H O O L  O F  M E D I C I N E  A L U M N U S 
B R AY L E Y  I S  P H Y S I C I A N  F O R  N B A’ S 
S A C R A M E N T O  K I N G S
By ARIN GENCER
S A C R A M E N T O ,  C A L I F O R N I A
Loma Linda in the World
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“The fellowship leaders 
thought it was a good idea for 
me to get my feet wet, so they 
supported me doing that on 
my own,” says Brayley, who 
had long followed professional 
cycling and done his share of 
road racing. “Being involved 
with a domestic professional 
cycling team was a great 
opportunity to expand taking 
care of athletes.”
After his fellowship, 
Brayley looked for jobs with 
a sports-medicine focus that 
also would bring him back 
to California. An opportunity 
with a Seattle-area healthcare 
system came first, and he and 
his young family headed west. 
Five years later, the position 
in Sacramento opened, and he 
jumped at the chance to work 
in Northern California.
In some ways, he’s come 
full circle: The Kings played 
in the first NBA game he 
ever attended.
“I look back in hindsight 
and realize how many of these 
little small things that seemed 
relatively unimportant at the 
time were part of the bigger 
picture,” Brayley says. 
“Every move I’ve made 
since high school and college 
is based on leaps of faith, and 
you feel like you’re sort of 
steered in one direction,” he 
says. “My wife and I felt like 
we’ve been led every step of 
the way.”
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Jason Brayley before a game in 
March. He typically arrives to 
games 90 minutes before tip off.
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The complexity of humanitarian work hit 
Canadian Elizabeth Tomenko as a new college 
graduate when she worked at a homeless shelter 
in the Downtown Eastside — a neighborhood 
in Vancouver, British Columbia, notorious 
for poverty, drug addicts, prostitutes and 
criminal runaways.
She worked in the kitchen and loved helping 
people eat healthy, but reality hit hard.
“We would put a salad before someone off 
the street, but they couldn’t eat it because they 
had no teeth. It was then I learned that health 
was a lot more complicated than telling someone 
to eat their veggies,” Tomenko says.
Since then, she’s gone on to work in the 
complex world of international humanitarian 
service, coordinating food and emergency support 
for tens of thousands. The 2014 graduate of 
Loma Linda University School of Public Health 
now works at the home office for the Adventist 
Development and Relief Agency (ADRA), which 
is based at the Seventh-day Adventist Church’s 
world headquarters in Silver Spring, Maryland. 
Her role as the Emergency Response Program 
Manager for Asia-Pacific and North America has 
taken her all over the globe and brought her face-
to-face with numerous humanitarian crises. 
Last year, her job at ADRA took her to the 
sprawling Rohingya refugee camps in Bangladesh. 
Hundreds of thousands of Rohingya, a stateless 
Muslim minority, have fled their homes in 
Myanmar because of violent persecution and are 
stuck in makeshift camps in a country that can 
ill-afford to help.
“It was debilitatingly heartbreaking,” she 
says about what she saw in the camps. “It’s 
extremely motivating to be there, but at the same 
time, you have to somewhat distance yourself 
from the people you are trying to help to be able 
to function.”
What was striking, she says, was just 40 
minutes away from the nearest camp was a resort 
town filled with tourists having a great time. 
“Vacationers were jet-skiing when, just down 
the road, I was in a camp filled with desperate, 
fearful, hungry families.”
She has helped coordinate responses 
to numerous massive emergency situations 
— everything from flooding in Nepal and 
Bangladesh to typhoons and volcanic eruptions 
in the Philippines to hurricanes and wildfires in 
North America.
Tomenko first joined ADRA in 2014 as the 
Adventist Church’s Ebola response coordinator, 
a newly-created position at the time to help 
several denominational entities respond to the 
Ebola outbreak in West Africa. She had been with 
World Vision when she learned ADRA needed 
someone in a temporary slot to help with that 
emergency. She got the job and, when the crisis 
abated, ADRA hired her permanently. 
When not in the field, Tomenko spends most 
of her time in the office, remotely coordinating 
and providing support to humanitarian activities 
across her region. “I’m on the phone and Skype a 
lot,” she says. “It’s not unheard of for me to be on 
a call at midnight when it’s business hours on the 
other side of the world.” 
T H E  E M E R G E N C Y  P R E PA R E R
School of Public Health alumna coordinates  
international support when tragedy strikes
By CLIFFORD GOLDSTEIN 
S I L V E R  S P R I N G ,  M A R Y L A N D
Loma Linda in the World
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Her support comes in the form of 
proposal writing and review, seeking 
and coordinating pooled funding for 
responses, and training country office 
staff. When necessary, she helps deploy 
extra teams to support emergency 
responses. Sometimes that means she 
goes herself. 
“I had less than 12 hours’ notice 
before deploying to Bangladesh for 
the Rohingya refugee crisis,” she says. 
“I had been planning a different trip 
but was advised to change it at the 
last minute.”
Tomenko’s interest in working 
internationally was piqued in high 
school when she went on a mission trip 
to Belize. Later, she went on several 
more trips, even living and studying 
in Thailand and teaching English in 
Albania before earning a degree in food, 
nutrition, and health science at the 
University of British Columbia.
From there, Tomenko came to Loma 
Linda University, where her love of 
travel, interest in nutrition, and desire 
to help others all coalesced when she 
earned her Master of Public Health 
degree in Global Health. Here, mentors 
and teachers encouraged her, helping 
her catch the vision that enabled her to 
take all her passions to their potential.
In the Integrated Community 
Development course, she spent part 
of a summer with several hands-on 
community health projects in Peru. 
She says the school provided great 
mentorship and opportunities to be 
involved and connected to church-based 
health systems and initiatives around 
the world. 
“I wouldn’t have gotten that 
networking or those opportunities 
anywhere else,” she says. 
For now, she’s watching out for 
other potential emergencies, monitoring 
a cyclone, a tropical storm and two 
volcanoes at once, and keeping in 
close contact with ADRA’s teams on 
the ground.
“In this world, you never know what 
is going to come next,” she says. “We 
need to be ready for anything.”
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Parting Shot
G O I N G  T W I C E
Auctioneer Jim Nye, left, works the audience at the 25th 
Anniversary Children’s Hospital Foundation Gala at the Riverside 
Convention Center in March to sell a painting by Jeff Hanson, right, a 
visually impaired philanthropic artist.
The painting sold for $24,000 — twice, with Hanson offering to 
paint a replica for a second bidder. Hanson then auctioned off his tie 
and cummerbund, which sold for $1,000.
The event raised $2.36 million for Loma Linda University 
Children’s Hospital services. 
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FOR PEOPLE WHO CARE
Retired banking VPs Yolanda and Dennis had their fi nancial future covered.
Once Dennis was diagnosed with prostate cancer, the family searched for 
stability and healing at Loma Linda University Heath (LLUH).
Given a second chance at life, the De La Paz’s were inspired to give back to 
LLUH through Planned Giving.
Their strategy was to include a charitable remainder clause in their 
revocable living trust.
Let us help you discover your Powerful Strategy.
MANY STRENGTHS. ONE MISSION.
Offi ce of Planned Giving
11175 Mountain View Avenue, Suite B, Loma Linda, CA 92354
909-558-4553  |  legacy@llu.edu  |  llulegacy.org
To read more about Dennis and Yolanda’s story, visit llulegacy.org/ps.
Yolanda and Dennis De La Paz
Revocable Living Trust with Charitable 
Remainder Clause 
Powerful 
Strategies 
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Encourage each other to know your cancer risk by visiting 
LomaLindaCancerQuiz.org. Loma Linda University Cancer Center 
has the latest screening technology for the early detection of breast 
and prostate cancer. We are the leading cancer center in the region, 
offering comprehensive care from diagnosis to survivorship. Cancer is 
not a choice. Choose to get a screening today.
We LIVE for early detection of breast and prostate cancer. 
For more information, visit LomaLindaCancerQuiz.org.
MANY STRENGTHS. ONE MISSION.
What is Your
Reason to 
get a Cancer
Screening?
